Diamyd Medical AB Release: Quarterly Report I 12/13
Regulatory News:
Quarterly Report 1, Diamyd Medical AB (publ) (STO:DIAMB)(Pink Sheets:DMYDY), fiscal year 2012/2013
Reporting period September 1, 2012 – November 30, 2012 • Group net sales amounted to MSEK 0 (0.2) • Loss before tax amounted to MSEK -1.8 (-3.5) • Earnings per share after dilution were SEK -0.2 (-0.3) • Liquid assets and short term investments amounted to MSEK 373 (414) as of November 30, 2012
Quarterly Report 1, Diamyd Medical AB (publ) (STO:DIAMB)(Pink Sheets:DMYDY), fiscal year 2012/2013
Reporting period September 1, 2012 – November 30, 2012 • Group net sales amounted to MSEK 0 (0.2) • Loss before tax amounted to MSEK -1.8 (-3.5) • Earnings per share after dilution were SEK -0.2 (-0.3) • Liquid assets and short term investments amounted to MSEK 373 (414) as of November 30, 2012